According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...
New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of ...
Chaos unfolded at Cooper Hospital following the death of a patient, as the medical staff faced aggression from the deceased's ...
Nuvalent is approaching the precipice of a first targeted therapy approval in lung cancer. Click here to read why NUVL stock ...
Compassus Health and Hospice Care consultant Kathy Rackers gave insight into end-of-life care to the Callaway Resource ...
New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and ...
It’s the first study to show a PCSK9 inhibitor can reduce major events in high-risk patients who haven’t yet had one.
THURSDAY, Nov. 6, 2025 (HealthDay News) — A new study suggests that many women with early-stage breast cancer may not need ...
Diverticulitis, once a concern for older adults, is now increasingly affecting Americans under 50. Hospitalizations for ...
More than 28% of lung cancers were detected early, when survival rates are better — a 12% improvement over five years. Also, ...
A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable cases of triple-negative breast cancer — a form of cancer that is ...